EP 2667852 B1 20161109 - ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS
Title (en)
ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS
Title (de)
ADJUVANTE NANOEMULSIONEN MIT KRISTALLISATIONSINHIBITOREN
Title (fr)
NANOÉMULSIONS D'ADJUVANT À INHIBITEURS DE CRISTALLISATION
Publication
Application
Priority
- US 201161436946 P 20110127
- US 2012022871 W 20120127
Abstract (en)
[origin: WO2012103421A1] High loading of lipophilic pharmacological agents (in particular, lipophilic immunopotentiators) in oil-in-water emulsions can result in crystallisation of the lipophilic agent. To overcome this problem the invention uses an oil-in-water emulsion in combination with a crystallisation inhibitor, and this combination provides emulsions which can be loaded with high levels of lipophilic pharmacological agents.
IPC 8 full level
A61K 9/107 (2006.01); A61K 31/4375 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/44 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 9/1075 (2013.01 - EP US); A61K 31/00 (2013.01 - EP US); A61K 31/4375 (2013.01 - EP US); A61K 31/4745 (2013.01 - EP US); A61K 39/095 (2013.01 - US); A61K 39/39 (2013.01 - EP US); A61K 47/26 (2013.01 - EP US); A61K 47/32 (2013.01 - EP US); A61K 47/44 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012103421 A1 20120802; EP 2667852 A1 20131204; EP 2667852 B1 20161109; ES 2612511 T3 20170517; US 10286056 B2 20190514; US 2014017279 A1 20140116
DOCDB simple family (application)
US 2012022871 W 20120127; EP 12704573 A 20120127; ES 12704573 T 20120127; US 201213982042 A 20120127